Standout Papers

Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase I... 2012 2026 2016 2021 959
  1. Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen (2012)
    Eric Van Cutsem, Josep Tabernero et al. Journal of Clinical Oncology

Immediate Impact

6 from Science/Nature 95 standout
Sub-graph 1 of 17

Citing Papers

Colorectal cancer
2024 Standout
A systems view of the vascular endothelium in health and disease
2024 Standout
1 intermediate paper

Works of R Castan being referenced

Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
2012 Standout

Author Peers

Author Last Decade Papers Cites
R Castan 380 808 12 284 6 1.0k
Joe McKendrick 407 845 17 288 9 1.1k
Alexia Tellier 382 847 8 281 4 1.0k
Yousif Abubakr 480 1068 17 330 7 1.2k
C. Schlichting 396 804 9 290 16 1.1k
Seta Shahin 315 794 47 183 13 925
Claus-Christoph Steffens 467 946 9 303 18 1.1k
Tarek Chidiac 378 783 15 184 16 985
Belguendouz Bendahmane 417 1053 27 290 16 1.2k
B. Nelson 274 774 18 196 11 1000
Frédérique Maindrault‐Gœbel 290 740 15 162 14 939

All Works

Loading papers...

Rankless by CCL
2026